These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 32679689)

  • 1. Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2) and Mitochondrial Dynamics/Mitophagy in Neurological Diseases.
    Kang TC
    Antioxidants (Basel); 2020 Jul; 9(7):. PubMed ID: 32679689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease.
    Misrani A; Tabassum S; Yang L
    Front Aging Neurosci; 2021; 13():617588. PubMed ID: 33679375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2/Nrf2 and mitochondria.
    Ryoo IG; Kwak MK
    Toxicol Appl Pharmacol; 2018 Nov; 359():24-33. PubMed ID: 30236989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 Activation Protects Mouse Beta Cells from Glucolipotoxicity by Restoring Mitochondrial Function and Physiological Redox Balance.
    Schultheis J; Beckmann D; Mulac D; Müller L; Esselen M; Düfer M
    Oxid Med Cell Longev; 2019; 2019():7518510. PubMed ID: 31827698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin and Nrf2 prevent oxidative stress-induced apoptosis in intervertebral endplate chondrocytes via inducing mitophagy and anti-oxidant defenses.
    Kang L; Liu S; Li J; Tian Y; Xue Y; Liu X
    Life Sci; 2020 Feb; 243():117244. PubMed ID: 31891721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
    Denzer I; Münch G; Friedland K
    Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dynamics and mitophagy in lung disorders.
    Sharma A; Ahmad S; Ahmad T; Ali S; Syed MA
    Life Sci; 2021 Nov; 284():119876. PubMed ID: 34389405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
    George M; Tharakan M; Culberson J; Reddy AP; Reddy PH
    Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 as a regulator of mitochondrial function: Energy metabolism and beyond.
    Esteras N; Abramov AY
    Free Radic Biol Med; 2022 Aug; 189():136-153. PubMed ID: 35918014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease.
    Li R; Toan S; Zhou H
    Aging (Albany NY); 2020 Mar; 12(7):6467-6485. PubMed ID: 32213662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
    Cheng X; Ku CH; Siow RC
    Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy.
    Van Laar VS; Roy N; Liu A; Rajprohat S; Arnold B; Dukes AA; Holbein CD; Berman SB
    Neurobiol Dis; 2015 Feb; 74():180-93. PubMed ID: 25478815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases.
    Gureev AP; Popov VN
    Neurochem Res; 2019 Oct; 44(10):2273-2279. PubMed ID: 30617864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.
    Bultman SJ; Holley DW; G de Ridder G; Pizzo SV; Sidorova TN; Murray KT; Jensen BC; Wang Z; Bevilacqua A; Chen X; Quintana MT; Tannu M; Rosson GB; Pandya K; Willis MS
    Cardiovasc Pathol; 2016; 25(3):258-269. PubMed ID: 27039070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
    de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
    Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhang J; Lv W; Zhang G; Zeng M; Cao W; Su J; Cao K; Liu J
    Antioxid Redox Signal; 2024 Mar; ():. PubMed ID: 38183629
    [No Abstract]   [Full Text] [Related]  

  • 18. Latest assessment methods for mitochondrial homeostasis in cognitive diseases.
    You W; Li Y; Liu K; Mi X; Li Y; Guo X; Li Z
    Neural Regen Res; 2024 Apr; 19(4):754-768. PubMed ID: 37843209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of MIEF1/MiD51 confers susceptibility to BAX-mediated cell death and PINK1-PRKN-dependent mitophagy.
    Xian H; Liou YC
    Autophagy; 2019 Dec; 15(12):2107-2125. PubMed ID: 30894073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multifaceted role of Nrf2 in mitochondrial function.
    Holmström KM; Kostov RV; Dinkova-Kostova AT
    Curr Opin Toxicol; 2016 Dec; 1():80-91. PubMed ID: 28066829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.